Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for EEG and postoperative delirium in elderly surgical patients
ChiCTR2100046742Phase 4Recruiting
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) (3 arms), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoints: Electroencephalogram, Mean arterial pressure and 4 more. Started Jun 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100046742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046742.